Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival

Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival

Introduction: Hypertension is common in patients with severe aortic stenosis undertaking transcatheter aortic valve replacement (TAVR). Renin–angiotensin system (RAS) blockade therapy with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) has recently been a...

Full description

Bibliographic Details
Main Author: Brent Klinkhammer
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2019-08-01
Series:Journal of Cardiovascular and Thoracic Research
Subjects:
antihypertensive agents
tavr
arb
ace inhibitor
Online Access:https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-11-176.pdf

Internet

https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-11-176.pdf

Similar Items